Market Place
Sourcing Support
All News #Library
Biotech
Alloy Therapeutics Raises $40M Series E for Its Biotech Platform
15 Apr 2026 //
PHARMIWEB
Alloy Therapeutics, Biogen Team Up on Anticlastic ASO
07 Apr 2026 //
PHARMIWEB
Biogen Links Up With Alloy Platform To Boost ASO Drug Development
07 Apr 2026 //
FIERCE BIOTECH
Alloy Enters Into Agreement to Advance Novel Antibody Platform
17 Mar 2026 //
BUSSINESSWIRE
Alloy Speeds Complex Fibrosis Targets Toward Clinical Trials
03 Feb 2026 //
PHARMIWEB
Tahoe & Alloy Form Venture for Novel Cancer ADCs for Cancers
13 Jan 2026 //
PHARMIWEB
Alloy, UBC Partner To Advance Antibody Discovery Via Cryo-EM
07 Oct 2025 //
PHARMIWEB
MultiOmic Health, Alloy Therapeutics Collaborate on Renal Drugs
02 Apr 2025 //
BUSINESSWIRE
Alloy Collaboration with Pfizer to Develop Antibody Platform
12 Feb 2025 //
BUSINESSWIRE
Alloy Launches ATX-Gx™ Licensing & mAbForge™ Screening Service
09 Jan 2025 //
BUSINESSWIRE
Sanofi partners with Alloy Therapeutics to make new CNS drug
08 Jan 2025 //
PRESS RELEASE
Alloy Partners with Takeda on iPSC-Derived Cell Therapies
20 Nov 2024 //
CONTRACTPHARMA
Alloy Therapeutics Licenses ATX-Gx™ Platform from Scripps Research
30 Oct 2024 //
BUSINESSWIRE
Alloy to Empower Drug Discovery of Lundbeck’s Biologics for Brain Health
02 May 2023 //
BUSINESSWIRE
Alloy Unveils 2023 Innovation Roadmap Across Antibodies & Genetic Medicines
09 Jan 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.